chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Within a week of vaccine started to have intense itching on back. A week later it progressed to the torso - both on the right side. Was diagnosed with shingles on April 18th and began a round of antiviral which reduced itching/burning sensation and reduced rash. Rash is now nearly gone although still feeling very fatigued.
318 patients received dose from vials beyond 30-day use by date; 318 patients received dose from vials beyond 30-day use by date ( In Refrigeration on 07-May-2021); This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (318 patients received dose from vials beyond 30-day use by date) and PRODUCT STORAGE ERROR (318 patients received dose from vials beyond 30-day use by date ( In Refrigeration on 07-May-2021)) in a 25-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 23-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Jun-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (318 patients received dose from vials beyond 30-day use by date) and PRODUCT STORAGE ERROR (318 patients received dose from vials beyond 30-day use by date ( In Refrigeration on 07-May-2021)). On 23-Jun-2021, EXPIRED PRODUCT ADMINISTERED (318 patients received dose from vials beyond 30-day use by date) and PRODUCT STORAGE ERROR (318 patients received dose from vials beyond 30-day use by date ( In Refrigeration on 07-May-2021)) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication was not provided.  Treatment information was not provided.
Dermatologist - gave Valtrex 16m + clobetasol ointment. Headache, rash, blisters open with liquid coming out . 3 day fever to 101.9 . Left ear - cannot hear dial tone - on phone. Did before worried better not yet, ok will, I be?.
This spontaneous report was received from a nurse referring to a patient of an unknown demographics. Information on patient's pertinent medical history and drug reactions/allergies were not reported. On 05-FEB-2018, the patient was vaccinated with properly stored expired VAQTA (strength, dose and frequency were not reported) (lot # M18767, expiration date: 01-FEB-2018) for prophylaxis (Expired product administered). No adverse events were reported. There was no product quality complaint (PQC) reported.
Woke up several days after the vaccination with severe tinnitus in both ears. Reported the tinnitus to my GP and was told simply to use a decongestant as there was nothing she could do. The tinnitus has never stopped since that day. Sometimes it is severe enough to interfere with conversation.  The tinnitus appears to be worse in my left ear. Since it has never receded since the onset, which is now many months, I can only assume this is now permanent.
I have redness about an inch below the injection site with fever in it.; fever; This is a spontaneous report from a contactable consumer (patient).  A female patient of an unspecified age received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number unknown), via an unspecified route of administration on 23Feb2021 as single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient had redness about an inch below the injection site with fever in it. One spot was one inch below and the size of a quarter but not round. It was sideways. It then breaks down into a lower spot that was a little bigger. Outcome of redness below the injection site and fever was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
High fever up to 105 within 24 hours of receiving 12 mos vaccines.  Evaluated by ED.  Tests and work up as cause for fever negative.  On day 10 of fever, developed diarrhea. Fever defervesced but diarrhea continued.  Stools cultures sent- positive for Salmonella.
extreme muscle weakness, difficulty breathing, swelling in chest/throat with a slow progression over a period of 5 days starting the day following immunization, did not seek medical attention
Approximately 3 to 4 hour after the vaccine my left eye started to hurt and feel like there was something in it and it swelled up.
fatigue; body aches; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (body aches) and FATIGUE (fatigue) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     Concurrent medical conditions included Thyroid disorder. Concomitant products included CALCIUM, VITAMINS NOS and SIMVASTATIN (STATIN [SIMVASTATIN]) for an unknown indication.    On 12-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-May-2021, the patient experienced MYALGIA (body aches). On 18-May-2021, the patient experienced FATIGUE (fatigue). On 13-May-2021, MYALGIA (body aches) had resolved. At the time of the report, FATIGUE (fatigue) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 18-May-2021, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Product known to be used by the patient, within two week prior to the event, included thyroid medicine. Treatment information was not provided.
Initial report received from a healthcare professional on 12 June 2014: A 50-years-old female patient, whose medical history and concomitant medications were not reported received an intramuscular dose of ADACEL in the left deltoid (batch number: U4869AA) on 16 May 2014. On 16 May 2014 i.e. on the same day of vaccination the patient experienced redness at the vaccination site. Patient also experienced "bicipital tendonitis" that persisted till the date of report i.e. until 12 June 2014. Laboratory investigations and corrective treatments were not reported. The outcome was unknown at this time of report. List of documents held by sender: none. Follow-up information received from a healthcare professional on 4 May 2015. The patients had a medical history of allergic rhinitis, migraines, asthma, depression/anxiety, GERD, hyperlipidemia and menorrhagia. It was also reported that patient had received Ventolin PRN, Maxalt PRN, ADVAIR, simvastatin, Tdap 0.5 ml on 14 May 2014 in left deltoid (batch no 44869AA, expiry date 2 October 2016). No corrective treatments were given to the patient except ibuprofen OTC PRN (recommendation). NO laboratory investigations were performed. It was also reported that the patients symptoms gradually improved no clear stop date reported.
Within the hour of MMR injection - client's husband called (10:30 AM) to say she was having some itching and rash on her legs. Advised to return to clinic - by 12:30 pm - rash gone - no itching. Symptoms gone. Did not return.
Patient received both the Flu and Typhoid shots in the left arm. After administering the Rabies shot in the right arm the patient fainted in her seat and was unconscious for ~30 seconds before recovering on her own. Patient did not want to call EMS and sat in the waiting area for about 30 minutes and spoke with her primary care provider over the phone before leaving. Patient was not displaying any other symptoms during that time period.
exposed to varicella 3wk ago;9MAR98 seen w/22 red, round lesions on scalp, face, neck, chest, back, abd, arms, legs;few are vesicular;mild itching;
Vaccinated for smallpox on L-Deltoid on 2/25/2003.  Awoke this morning (day 15) with vesicles scattered on L-arm.  No c/o itching, burning or pain.  Temperature 96 degrees.  Questionable zoster or vaccinia reaction.  Lab sample to be taken tomorrow morning.
vaccine. No additional AEs were reported,; a patient received improperly stored vaccine.; This spontaneous report was received from a physician and refers to a patient of unknown gender and age. The patient's medical history, concurrent conditions and concomitant therapies were not reported.  On 09-SEP-2022, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (rHA) subcutaneous injection, lot number U028178, expiration date: 08-MAR-2023, administered for prophylaxis (dose, strength, and route of administration were not provided). Before the administration, the vaccine was improperly stored (temperature: -12.5 Celsius degrees, time frame: 1 hour, no previous temperature excursion) (product storage error). No additional adverse event was reported (no adverse event).
During mass Flu Clinic for adults and children I gave "Fluarix" to a child, meant for adults 18 years and older by mistake. No known adverse events.
Headache, aches, chills, feverish, no appetite, fatigue. Vomited three times during the first night & once next morning. Had to remain in bed entire next day. No appetite. Sore arm got worse after 2 days. Symptoms subsided on fourth day, except still have sore arm.
feeling sick; flu like symptoms; Initial information was received on 24-Nov-2021 regarding an unsolicited valid non-serious case received from a consumer/non-healthcare professional via pharmacy.  This case involves a 61-year-old male patient who had flu like symptoms (influenza like illness) and feeling sick (malaise) after receiving INFLUENZA VACCINE and TREPROSTINIL SODIUM [REMODULIN].  The patient's past medical treatment(s), vaccination(s) and family history were not provided.  At the time of the event, the patient had ongoing Pulmonary arterial hypertension.  It is unknown if the patient had any additional medical history, concomitant disease or risk factor.  Details for the concomitant medication was not reported.  On 28-Sep-2020, the patient started taking REMODULIN (TREPROSTINIL SODIUM) (formulation: unknown; concentration 2.5 mg/ml; lot number and expiry date: not reported) current dose was reported as 0.040 µg/kg continuous via intravenous (IV) route for Pulmonary arterial hypertension.  On an unknown date in Oct-2021, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date: not reported) via unknown route in unknown administration site for prophylactic vaccination. It was reported that the patient got his flu vaccine last week.  On 31-OCT-2021 (yesterday) the patient developed non-serious flu like symptoms (influenza like illness) and feeling sick (malaise) (unknown latency) following the administration of INFLUENZA VACCINE and 1 year 1 month 3 days after following the first dose intake of REMODULIN (TREPROSTINIL SODIUM).  It is unknown if the patient experienced any additional symptoms/events.  It is unknown if there were lab data/results available.  The patient would follow up with his primary care physician.  Action taken with IV Remodulin was not changed due to the events of malaise and influenza like illness.  It was not reported if the patient received a corrective treatment for the events.  At time of this report, the outcome of the event was reported as unknown.  There will be no information available on batch number for this case.
Patient developed fever and severe weakness about 24 hours after second COVID-19 vaccine. Spouse called ambulance and taken to the ED. Patient unable to get out of bed by self due to weakness. Patient admitted to observation unit due to fever and fatique for PT and strengthening.
Patient had pain upon injection and immediately after injection pain and has been continuously hurting. Arm appears swollen. Constant level 5 pain can go up to an 8 level of pain. Limited mobility on arm. Cannot raise above head. Sometime uses right arm to lift left arm. Tingling in fingers comes and goes. Patient has tried APAP and Ibuprofen without success.
"  Code called for a 36 YOF complaining of anaphylactic reaction after receiving COVID vaccine. Per staff, patient began to have hives around mouth and a tingling in mouth. RN on scene administered epi pen at 1310. Patient found awake and alert, in no distress. Team took over care of patient to bring down to ER. Pt VS WNL: BP 158/80, HR 122, RR 18 (post epi pen). Skin parameters WNL with vanishing hives. Patient brought to ED 09 for evaluation. "
Patient experienced itching at her scalp about 3 hours after her vaccine administration.   Patient took Benadryl as her doctor suggested but did not help. She also experienced vomiting, diarrhea, and reported fever of 105 F.   Skin rash/hives spread throughout her body, and she was admitted to the hospital.  Patient was discharged either 9/19/21 or 9/20/21.  Her symptoms resolved but still felt a bit shaky.
This initial spontaneous report was received from a healthcare worker referring to unspecified number of patients of unknown ages and genders. There was no pertinent medical history or drug allergies/drug reactions reported. The reporter stated that since 08JUN2015, the patients were administered with an unspecified number of improperly stored doses of ROTATEQ oral liquid (lot # K015816 with expiration date 29MAY2016, lot # K013868 with expiration date 27MAY2016 and lot # K020182 with expiration date 25JUN2016; dose was not provided. There was no concomitant medication. It was unknown if the patients sought medical. Product quality complaint was not involved. No adverse experiences were reported.
Pt recvd vax 26OCT92 & 29OCT92 devel generalized non-itching body rash; also devel periorbital edema; t98.8; 5NOV92 presented to MD w/inc rash, redness & itching; pityriasis rosea; redness, rash & some peeling skin;
This spontaneous report as received from a healthcare worker refers to unspecified number of patients. On unknown dates, the patients were vaccinated with LIQUID PEDVAXHIB exposed to 25F for over 3 months, which was an excursion that was unsupported by in-house stability date. The reporter was unable to provide administration dates, however provided the lot#/expired date as follows: lot # H017030/expire date 17-JAN-2015, lot # J000360/expire date 25-OCT-2015). No adverse symptoms provided at the time of report. This is one of several reports received from the some source. Additional information has been requested.
LOC FOR APPROX. 10 SECONDS, LOW B/PS, PALE, CLAMMY, EXTREME THIRST.
Honeycomb like marks down through my left arm that is spreading on the left side of my back. It is painful and hurts too touch.
This spontaneous report as received from a healthcare worker refers to a patient of unknown age and gender. No medical history and concurrent conditions were reported. On 01-DEC-2015 the patients was vaccinated with dose of improperly stored (Oka/Merck) VARIVAX (lot # K006135 with expiration date: 29-APR-2016) (dosing regimen and frequency unknown). No concomitant medications were reported. No adverse effects were reported. The administered dose experienced a temperature excursion of 71 degrees Fahrenheit for 30 minutes. There was no previous temperature excursion. This is one of the many reports from the same source. Additional information has been requested.
This spontaneous report as received from a physician refers to a 22 year old female patient with reflux and no known drug reactions/allergies. On unknown dates the patient was vaccinated with three doses of GARDASIL (dose and route was not reported). Concomitant therapies included PRILOSEC. In approximately May 2013, a routine Papanicolaou (PAP) Smear was positive for HPV on an unspecified date a year ago. Physician additionally stated there was "no inflammation". No treatment was given for the patient. No result from a repeat PAP smear obtained on 22-MAY-2014 was available yet. At the time of the report, the outcome of the event was unknown. Additional information has been requested.
I developed tachycardia with over 130 bpm and increased anxiety and restlessness. My husband took me to the doctor office. They performed an EKG and blood tests. Everything came out normal. Doctor said it could have been an allergic reaction to the vaccine or its components. Recommended to keep taking my anxiety medication and report it to my primary care physician. The tachycardia lasted for 18 hours. It was a scary situation I don't want to go thru again. I'm not taking the second shot!
This spontaneous report as received from a licensed vocational nurse refers to a 7 year old female patient. The patient had no illness at time of vaccination. No information on patient's medical history or concomitant medications was provided. On 17-SEP-2015 at 02:28 PM, the patient was vaccinated with the first dose of VARIVAX, injection, lot # L010145, subcutaneously in the right arm (dose and expiration date were not provided) that was improperly stored. The patient's concomitant vaccines given on the same date and time included HAVRIX (ped-adol, first dose, intramuscularly in the right arm) and poliovirus vaccine inactivated (unspecified) (manufacturer reported as Sanofi, fifth dose (4 doses given elsewhere), intramuscularly in the left arm). No adverse effects were reported.
Horrible nerve pain for 3 years can't wear jeans anymore; This case was reported by a consumer via interactive digital media and described the occurrence of nerve pain in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced nerve pain. On an unknown date, the outcome of the nerve pain was not recovered/not resolved.   It was unknown if the reporter considered the nerve pain to be related to Shingles vaccine.  Additional details were reported as follows: This case was reported for patient herself/himself. The age at vaccination was not reported. The patient had horrible nerve pain for 3 years and could not wear jeans anymore. The people thought that the patient was pretending this horrible pain. No further information was reported. Follow up was not possible as no contact details were provided. This case has been linked with US2021AMR129910, reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR129910:Same reporter.
Information has been received from a lawyer regarding a case in litigation concerning a female patient (age unknown). The patient's medical history, concurrent conditions and concomitant medication use were not provided. In 2013, the patient was vaccinated with ZOSTAVAX, (lot# and route unknown) for routine adult health maintenance for the prevention of shingles. The vaccine did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster, also known as shingles and other complications. Later in 2013, the patient was treated by a physician for a blistering vesicular outbreak that was diagnosed as severe herpes zoster or shingles. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering and other damages. Additional information has been requested.
Felt just like when I had Covid; body hurt extremely. Weakness. Lack of appetite. Headache. Low fever. Shivers.
Covid-19; A spontaneous report was received from a consumer concerning a female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced covid 19.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On unknown date, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: Unknown) via unknown route for prophylaxis of COVID-19 infection.  On an unknown date, the patient Tested positive for COVID 19.No laboratory details was provided.Treatment details included, Bamlanivimab was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event covid 19 was unknown at the time of the report.
Pt received dose at 3:40 pm. Experienced headache in about 2 hrs extreme chills causing shaking in 4 hrs. Fever of 103 in 8 hrs. Pt took APAP & vomited. Symptoms resolved by morning. Experienced body ache for 24 hour, then without any further problems.
vaccines stored in the refrigerator that underwent several temperature excursions; No adverse event; vaccines stored in the refrigerator that underwent several temperature excursions; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (vaccines stored in the refrigerator that underwent several temperature excursions), POOR QUALITY PRODUCT ADMINISTERED (vaccines stored in the refrigerator that underwent several temperature excursions) and NO ADVERSE EVENT (No adverse event) in a 23-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7146B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 17-Sep-2022 at 6:41 PM, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) .5 dosage form. On 17-Sep-2022 at 6:41 PM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (vaccines stored in the refrigerator that underwent several temperature excursions). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (vaccines stored in the refrigerator that underwent several temperature excursions) and NO ADVERSE EVENT (No adverse event). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (vaccines stored in the refrigerator that underwent several temperature excursions), POOR QUALITY PRODUCT ADMINISTERED (vaccines stored in the refrigerator that underwent several temperature excursions) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for PRODUCT TEMPERATURE EXCURSION ISSUE (vaccines stored in the refrigerator that underwent several temperature excursions) and POOR QUALITY PRODUCT ADMINISTERED (vaccines stored in the refrigerator that underwent several temperature excursions).    Concomitant medication information was not provided.  The nurse reported about Moderna monovalent and bivalent vaccines stored in the refrigerator that underwent several temperature excursions going back to Aug-2022 that were administered to patients.  The patient received first, second and third doses of Moderna COVID-19 vaccine via intramuscular route and site of administration was reported as deltoid muscle.  The patient received the fourth dose of Moderna COVID-19 bivalent vaccine on deltoid muscle.  No treatment information was provided.